Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 167 articles:
HTML format
Text format



Single Articles


    January 2019
  1. CHOI IA, Lee JS, Song YW, Lee EY, et al
    Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study.
    PLoS One. 2019;14:e0210471.
    PubMed     Text format     Abstract available


  2. CHU KA, Chen W, Hsu CY, Hung YM, et al
    Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan.
    PLoS One. 2019;14:e0210750.
    PubMed     Text format     Abstract available


  3. LILLEGRAVEN S, Greenberg JD, Reed GW, Saunders K, et al
    Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
    PLoS One. 2019;14:e0210459.
    PubMed     Text format     Abstract available


  4. TOKAI N, Yoshida S, Kotani T, Yoshikawa A, et al
    Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    PLoS One. 2019;14:e0211750.
    PubMed     Text format     Abstract available


  5. RAZI B, Reykandeh SE, Alizadeh S, Amirzargar A, et al
    TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0211146.
    PubMed     Text format     Abstract available


  6. GOMIDES APM, de Albuquerque CP, Santos ABV, Amorim RBC, et al
    Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    PLoS One. 2019;14:e0213219.
    PubMed     Text format     Abstract available


  7. GASSERT FT, Gassert FG, Topping GJ, Rummeny EJ, et al
    SNR analysis of contrast-enhanced MR imaging for early detection of rheumatoid arthritis.
    PLoS One. 2019;14:e0213082.
    PubMed     Text format     Abstract available


  8. FERREIRO-IGLESIAS A, Montes A, Perez-Pampin E, Canete JD, et al
    Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    PLoS One. 2019;14:e0213073.
    PubMed     Text format     Abstract available


  9. VEYSSIERE M, Perea J, Michou L, Boland A, et al
    A novel nonsense variant in SUPT20H gene associated with Rheumatoid Arthritis identified by Whole Exome Sequencing of multiplex families.
    PLoS One. 2019;14:e0213387.
    PubMed     Text format     Abstract available


  10. BADR MT, Hacker G
    Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.
    PLoS One. 2019;14:e0213470.
    PubMed     Text format     Abstract available


  11. DARGHAM SR, Zahirovic S, Hammoudeh M, Al Emadi S, et al
    Correction: Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    PLoS One. 2019;14:e0214258.
    PubMed     Text format     Abstract available


  12. GOMIDES APM, de Albuquerque CP, Santos ABV, Amorim RBC, et al
    Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    PLoS One. 2019;14:e0215198.
    PubMed     Text format     Abstract available


  13. MAKIN K, Easter T, Kemp M, Kendall P, et al
    Undetectable mannose binding lectin is associated with HRCT proven bronchiectasis in rheumatoid arthritis (RA).
    PLoS One. 2019;14:e0215051.
    PubMed     Text format     Abstract available


  14. GONZALEZ-ALVARO I, Castrejon I, Carmona L
    The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity.
    PLoS One. 2019;14:e0214717.
    PubMed     Text format     Abstract available


  15. SUNG YK, Yoshida K, Prince FHM, Frits ML, et al
    Prevalence and predictors for sustained remission in rheumatoid arthritis.
    PLoS One. 2019;14:e0214981.
    PubMed     Text format     Abstract available


  16. HARRISON M, Spooner L, Bansback N, Milbers K, et al
    Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals.
    PLoS One. 2019;14:e0216075.
    PubMed     Text format     Abstract available


  17. GARCIA-MORENO C, Gomara MJ, Bleda MJ, Sanmarti R, et al
    Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.
    PLoS One. 2019;14:e0215927.
    PubMed     Text format     Abstract available


  18. EBINA K, Hashimoto M, Yamamoto W, Hirano T, et al
    Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.
    PLoS One. 2019;14:e0216624.
    PubMed     Text format     Abstract available


  19. PAN Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, et al
    Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    PLoS One. 2019;14:e0215999.
    PubMed     Text format     Abstract available


  20. ENGLBRECHT M, Alten R, Aringer M, Baerwald CG, et al
    New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.
    PLoS One. 2019;14:e0217412.
    PubMed     Text format     Abstract available


  21. HOLMES CL, Peyton CG, Bier AM, Donlon TZ, et al
    Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.
    PLoS One. 2019;14:e0217221.
    PubMed     Text format     Abstract available


  22. VLIETSTRA L, Stebbings S, Meredith-Jones K, Abbott JH, et al
    Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity.
    PLoS One. 2019;14:e0217462.
    PubMed     Text format     Abstract available


  23. PILGAARD T, Hagelund L, Stallknecht SE, Jensen HH, et al
    Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study.
    PLoS One. 2019;14:e0218831.
    PubMed     Text format     Abstract available


  24. SASAKI C, Hiraishi T, Oku T, Okuma K, et al
    Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis.
    PLoS One. 2019;14:e0219400.
    PubMed     Text format     Abstract available


    January 2018
  25. FENG X, Tian M, Zhang W, Mei H, et al
    Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.
    PLoS One. 2018;13:e0190798.
    PubMed     Text format     Abstract available


  26. LIN TM, Chen WS, Sheu JJ, Chen YH, et al
    Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study.
    PLoS One. 2018;13:e0186475.
    PubMed     Text format     Abstract available


  27. TERATO K, Waritani T, Fukai R, Shionoya H, et al
    Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis.
    PLoS One. 2018;13:e0190588.
    PubMed     Text format     Abstract available


  28. KANEKO C, Kobayashi T, Ito S, Sugita N, et al
    Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study.
    PLoS One. 2018;13:e0192365.
    PubMed     Text format     Abstract available


  29. BELL RD, Rudmann C, Wood RW, Schwarz EM, et al
    Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
    PLoS One. 2018;13:e0190678.
    PubMed     Text format     Abstract available


  30. GUO Y, Walsh AM, Canavan M, Wechalekar MD, et al
    Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.
    PLoS One. 2018;13:e0192704.
    PubMed     Text format     Abstract available


  31. DE JONG HJI, Cohen Tervaert JW, Lalmohamed A, de Vries F, et al
    Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.
    PLoS One. 2018;13:e0193297.
    PubMed     Text format     Abstract available


  32. HUA J, Huang W
    Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations.
    PLoS One. 2018;13:e0193674.
    PubMed     Text format     Abstract available


  33. TAVERNER D, Vallve JC, Ferre R, Paredes S, et al
    Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.
    PLoS One. 2018;13:e0193690.
    PubMed     Text format     Abstract available


  34. EBINA K, Hashimoto M, Yamamoto W, Ohnishi A, et al
    Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
    PLoS One. 2018;13:e0194130.
    PubMed     Text format     Abstract available


  35. AUDO R, Deckert V, Daien CI, Che H, et al
    PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.
    PLoS One. 2018;13:e0193815.
    PubMed     Text format     Abstract available


  36. SUZUKI K, Nakashima A, Igarashi M, Saito K, et al
    Euglena gracilis Z and its carbohydrate storage substance relieve arthritis symptoms by modulating Th17 immunity.
    PLoS One. 2018;13:e0191462.
    PubMed     Text format     Abstract available


  37. DHAOUADI T, Chahbi M, Haouami Y, Sfar I, et al
    IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0194883.
    PubMed     Text format     Abstract available


  38. MORITA Y, Ito H, Torii M, Hanai A, et al
    Factors affecting walking ability in female patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0195059.
    PubMed     Text format     Abstract available


  39. MACIAS-SEGURA N, Castaneda-Delgado JE, Bastian Y, Santiago-Algarra D, et al
    Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.
    PLoS One. 2018;13:e0194205.
    PubMed     Text format     Abstract available


  40. CHOI ST, Lee KH
    Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    PLoS One. 2018;13:e0195550.
    PubMed     Text format     Abstract available


  41. SHI Q, Li KJ, Treuer T, Wang BCM, et al
    Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD).
    PLoS One. 2018;13:e0193489.
    PubMed     Text format     Abstract available


  42. UUTELA TI, Kautiainen HJ, Hakkinen AH
    Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0194917.
    PubMed     Text format     Abstract available


  43. OTSUKA Y, Kiyohara C, Kashiwado Y, Sawabe T, et al
    Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
    PLoS One. 2018;13:e0196368.
    PubMed     Text format     Abstract available


  44. LOPEZ-RODRIGUEZ R, Perez-Pampin E, Marquez A, Blanco FJ, et al
    Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
    PLoS One. 2018;13:e0196793.
    PubMed     Text format     Abstract available


  45. GHITI MOGHADAM M, Lamers-Karnebeek FBG, Vonkeman HE, Ten Klooster PM, et al
    Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.
    PLoS One. 2018;13:e0192425.
    PubMed     Text format     Abstract available


  46. ANDERSEN M, Boesen M, Ellegaard K, Soderstrom K, et al
    Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.
    PLoS One. 2018;13:e0197001.
    PubMed     Text format     Abstract available


  47. LOPES AP, Hillen MR, Chouri E, Blokland SLM, et al
    Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren's syndrome.
    PLoS One. 2018;13:e0193157.
    PubMed     Text format     Abstract available


  48. PANEZAI J, Ghaffar A, Altamash M, Engstrom PE, et al
    Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0197235.
    PubMed     Text format     Abstract available


  49. PANGA V, Raghunathan S
    A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis.
    PLoS One. 2018;13:e0199530.
    PubMed     Text format     Abstract available


  50. CHOI S, Lee KH
    Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    PLoS One. 2018;13:e0199468.
    PubMed     Text format     Abstract available


  51. HUGHES-AUSTIN JM, Deane KD, Giles JT, Derber LA, et al
    Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients.
    PLoS One. 2018;13:e0199578.
    PubMed     Text format     Abstract available


  52. KIM JY, Lim K, Kim KH, Kim JH, et al
    N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis.
    PLoS One. 2018;13:e0194331.
    PubMed     Text format     Abstract available


  53. SCHARMGA A, Peters M, van den Bergh JP, Geusens P, et al
    Development of a scoring method to visually score cortical interruptions on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis and healthy controls.
    PLoS One. 2018;13:e0200331.
    PubMed     Text format     Abstract available


  54. TSUJIMOTO S, Mokuda S, Matoba K, Yamada A, et al
    The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0200023.
    PubMed     Text format     Abstract available


  55. CHEN KC, Wu CH, Tang CH, Huang KC, et al
    Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database.
    PLoS One. 2018;13:e0200758.
    PubMed     Text format     Abstract available


  56. CHIU YM, Lai MS, Chan KA
    Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
    PLoS One. 2018;13:e0196210.
    PubMed     Text format     Abstract available


  57. TAKAGI Y, Nakamura H, Sumi M, Shimizu T, et al
    Combined classification system based on ACR/EULAR and ultrasonographic scores for improving the diagnosis of Sjogren's syndrome.
    PLoS One. 2018;13:e0195113.
    PubMed     Text format     Abstract available


  58. LINDNER MD, Torralba KD, Khan NA
    Scientific productivity: An exploratory study of metrics and incentives.
    PLoS One. 2018;13:e0195321.
    PubMed     Text format     Abstract available


  59. LIU M, Degner J, Davis JW, Idler KB, et al
    Identification of HLA-DRB1 association to adalimumab immunogenicity.
    PLoS One. 2018;13:e0195325.
    PubMed     Text format     Abstract available


  60. WHEATER G, Elshahaly M, Naraghi K, Tuck SP, et al
    Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study.
    PLoS One. 2018;13:e0201527.
    PubMed     Text format     Abstract available


  61. WAKABAYASHI A, Ishiguro T, Takaku Y, Miyahara Y, et al
    Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0201799.
    PubMed     Text format     Abstract available


  62. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    Differential effects of TNF-alpha and IL-1beta on the control of metal metabolism and cadmium-induced cell death in chronic inflammation.
    PLoS One. 2018;13:e0196285.
    PubMed     Text format     Abstract available


  63. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    PubMed     Text format     Abstract available


  64. TOKAI N, Yoshida S, Kotani T, Yoshikawa A, et al
    Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0202601.
    PubMed     Text format     Abstract available


  65. OMA I, Olstad OK, Andersen JK, Lyberg T, et al
    Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0202346.
    PubMed     Text format     Abstract available


  66. LEBLOND A, Pezet S, Trouvin AP, Elhai M, et al
    Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.
    PLoS One. 2018;13:e0203607.
    PubMed     Text format     Abstract available


  67. YANO K, Ikari K, Inoue E, Sakuma Y, et al
    Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort.
    PLoS One. 2018;13:e0202427.
    PubMed     Text format     Abstract available


  68. FURUKAWA H, Oka S, Shimada K, Hashimoto A, et al
    Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations.
    PLoS One. 2018;13:e0204459.
    PubMed     Text format     Abstract available


  69. HARTJEN N, Brauer L, Reiss B, Claassen H, et al
    Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
    PLoS One. 2018;13:e0203502.
    PubMed     Text format     Abstract available


  70. BEYER K, Zaura E, Brandt BW, Buijs MJ, et al
    Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health.
    PLoS One. 2018;13:e0202278.
    PubMed     Text format     Abstract available



  71. Retraction: Identification of Autoantibodies against Transthyretin for the Screening and Diagnosis of Rheumatoid Arthritis.
    PLoS One. 2018;13:e0205914.
    PubMed     Text format    


  72. VOGELZANG EH, Hebing RCF, Nurmohamed MT, van Kuijk AWR, et al
    Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
    PLoS One. 2018;13:e0205125.
    PubMed     Text format     Abstract available


  73. ALEMAO E, Al MJ, Boonen AA, Stevenson MD, et al
    Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.
    PLoS One. 2018;13:e0205013.
    PubMed     Text format     Abstract available


  74. JUNG SM, Kwok SK, Ju JH, Lee SW, et al
    Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry.
    PLoS One. 2018;13:e0205651.
    PubMed     Text format     Abstract available


  75. WATERBORG CEJ, Koenders MI, van Lent PLEM, van der Kraan PM, et al
    Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
    PLoS One. 2018;13:e0205902.
    PubMed     Text format     Abstract available


  76. NAKAGAWA S, Nakaishi M, Hashimoto M, Ito H, et al
    Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0206943.
    PubMed     Text format     Abstract available


  77. SATO T, Hatano M, Iwasaki Y, Maki H, et al
    Prevalence of primary Sjogren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.
    PLoS One. 2018;13:e0197297.
    PubMed     Text format     Abstract available


  78. CHIN CY, Hsieh SY, Tseng VS
    eDRAM: Effective early disease risk assessment with matrix factorization on a large-scale medical database: A case study on rheumatoid arthritis.
    PLoS One. 2018;13:e0207579.
    PubMed     Text format     Abstract available


  79. MASUOKA S, Kusunoki N, Takamatsu R, Takahashi H, et al
    Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovialtissues of rheumatoid arthritis.
    PLoS One. 2018;13:e0208957.
    PubMed     Text format     Abstract available


  80. DE ROTTE MCFJ, Pluijm SMF, de Jong PHP, Bulatovic Calasan M, et al
    Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    PLoS One. 2018;13:e0208534.
    PubMed     Text format     Abstract available


  81. DARGHAM SR, Zahirovic S, Hammoudeh M, Al Emadi S, et al
    Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    PLoS One. 2018;13:e0208240.
    PubMed     Text format     Abstract available


  82. JEONG DH, Kang J, Jung YJ, Yoo B, et al
    Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    PLoS One. 2018;13:e0198756.
    PubMed     Text format     Abstract available


  83. SU H, Rei N, Zhang L, Cheng J, et al
    Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases.
    PLoS One. 2018;13:e0198693.
    PubMed     Text format     Abstract available


  84. SAAD MN, Mabrouk MS, Eldeib AM, Shaker OG, et al
    Comparative study for haplotype block partitioning methods - Evidence from chromosome 6 of the North American Rheumatoid Arthritis Consortium (NARAC) dataset.
    PLoS One. 2018;13:e0209603.
    PubMed     Text format     Abstract available


  85. WANG X, Shaalan A, Liefers S, Coudenys J, et al
    Dysregulation of NF-kB in glandular epithelial cells results in Sjogren's-like features.
    PLoS One. 2018;13:e0200212.
    PubMed     Text format     Abstract available


  86. CHEN HH, Chao WC, Liao TL, Lin CH, et al
    Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
    PLoS One. 2018;13:e0201340.
    PubMed     Text format     Abstract available


  87. MCKELVEY KJ, Millier MJ, Doyle TC, Stamp LK, et al
    Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation.
    PLoS One. 2018;13:e0202135.
    PubMed     Text format     Abstract available


  88. REGUEIRO C, Ortiz AM, Boveda MD, Castaneda S, et al
    Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
    PLoS One. 2018;13:e0202583.
    PubMed     Text format     Abstract available


  89. TAKAMURA Y, Aoki W, Satomura A, Shibasaki S, et al
    Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-alpha stimulation.
    PLoS One. 2018;13:e0201851.
    PubMed     Text format     Abstract available


  90. SCHRIMPF A, Brodje D, Pfefferle P, Geyer A, et al
    A set of conformationally well-defined L/D-peptide epitopes provides a serological bar code for autoantibody subtypes.
    PLoS One. 2018;13:e0201735.
    PubMed     Text format     Abstract available


  91. DAMGAARD D, Bawadekar M, Senolt L, Stensballe A, et al
    Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    PLoS One. 2018;13:e0203214.
    PubMed     Text format     Abstract available


  92. WOLFE F, Walitt B, Perrot S, Rasker JJ, et al
    Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias.
    PLoS One. 2018;13:e0203755.
    PubMed     Text format     Abstract available


  93. AQRAWI LA, Chen X, Jensen JL, Morthen MK, et al
    Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjogren's syndrome.
    PLoS One. 2018;13:e0205762.
    PubMed     Text format     Abstract available


    January 2017
  94. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0174656.
    PubMed     Text format     Abstract available


  95. HALLAJZADEH J, Safiri S, Mansournia MA, Khoramdad M, et al
    Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.
    PLoS One. 2017;12:e0170361.
    PubMed     Text format     Abstract available


  96. PARADOWSKA-GORYCKA A, Sowinska A, Pawlik A, Malinowski D, et al
    FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.
    PLoS One. 2017;12:e0172018.
    PubMed     Text format     Abstract available


  97. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0175605.
    PubMed     Text format     Abstract available


  98. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  99. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    PLoS One. 2017;12:e0175207.
    PubMed     Text format     Abstract available


  100. BOO S, Oh H, Froelicher ES, Suh CH, et al
    Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0176291.
    PubMed     Text format     Abstract available


  101. IWAMOTO N, Tsuji S, Takatani A, Shimizu T, et al
    Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0177057.
    PubMed     Text format     Abstract available


  102. KOGA T, Okada A, Fukuda T, Hidaka T, et al
    Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.
    PLoS One. 2017;12:e0175281.
    PubMed     Text format     Abstract available


  103. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0178309.
    PubMed     Text format     Abstract available


  104. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Text format     Abstract available


  105. MORI S, Yoshitama T, Hidaka T, Sakai F, et al
    Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
    PLoS One. 2017;12:e0179179.
    PubMed     Text format     Abstract available


  106. MATEEN S, Moin S, Shahzad S, Khan AQ, et al
    Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species.
    PLoS One. 2017;12:e0178879.
    PubMed     Text format     Abstract available


  107. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventi
    PLoS One. 2017;12:e0179308.
    PubMed     Text format     Abstract available


  108. BUONDONNO I, Rovera G, Sassi F, Rigoni MM, et al
    Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.
    PLoS One. 2017;12:e0178463.
    PubMed     Text format     Abstract available


  109. HUNG YM, Lin L, Chen CM, Chiou JY, et al
    The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.
    PLoS One. 2017;12:e0179081.
    PubMed     Text format     Abstract available


  110. ZOU K, Xiao FK, Li HY, Zhou Q, et al
    Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years.
    PLoS One. 2017;12:e0180376.
    PubMed     Text format     Abstract available


  111. VIDAL-BRALO L, Perez-Pampin E, Regueiro C, Montes A, et al
    Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
    PLoS One. 2017;12:e0180144.
    PubMed     Text format     Abstract available


  112. MURPHY D, Mattey D, Hutchinson D
    Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    PLoS One. 2017;12:e0180655.
    PubMed     Text format     Abstract available


  113. LOUPASAKIS K, Kuo D, Sokhi UK, Sohn C, et al
    Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0179762.
    PubMed     Text format     Abstract available


  114. RUSCITTI P, Ursini F, Cipriani P, Liakouli V, et al
    Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
    PLoS One. 2017;12:e0181203.
    PubMed     Text format     Abstract available


  115. WANG W, Liu J, Yang B, Ma Z, et al
    Modulation of platelet-derived microparticles to adhesion and motility of human rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0181003.
    PubMed     Text format     Abstract available


  116. HUANG CM, Chen HH, Chen DC, Huang YC, et al
    Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein.
    PLoS One. 2017;12:e0180604.
    PubMed     Text format     Abstract available


  117. GILLOOLY KM, Pulicicchio C, Pattoli MA, Cheng L, et al
    Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
    PLoS One. 2017;12:e0181782.
    PubMed     Text format     Abstract available


  118. LUUKKONEN J, Pascual LM, Patlaka C, Lang P, et al
    Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
    PLoS One. 2017;12:e0182904.
    PubMed     Text format     Abstract available


  119. VAANANEN T, Vuolteenaho K, Kautiainen H, Nieminen R, et al
    Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.
    PLoS One. 2017;12:e0183294.
    PubMed     Text format     Abstract available


  120. TUNG CH, Lu MC, Lai NS, Wu SF, et al
    Tumor necrosis factor-alpha blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.
    PLoS One. 2017;12:e0183726.
    PubMed     Text format     Abstract available


  121. HURNAKOVA J, Hulejova H, Zavada J, Hanova P, et al
    Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
    PLoS One. 2017;12:e0183420.
    PubMed     Text format     Abstract available


  122. CHEN JQ, Papp G, Poliska S, Szabo K, et al
    MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren's syndrome.
    PLoS One. 2017;12:e0174585.
    PubMed     Text format     Abstract available


  123. JEONG S, Yang H, Hwang H
    Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.
    PLoS One. 2017;12:e0173597.
    PubMed     Text format     Abstract available


  124. STONE DU, Fife D, Brown M, Earley KE, et al
    Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjogren's Syndrome.
    PLoS One. 2017;12:e0170249.
    PubMed     Text format     Abstract available


  125. PASMA A, Schenk C, Timman R, van 't Spijker A, et al
    Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?
    PLoS One. 2017;12:e0171070.
    PubMed     Text format     Abstract available


  126. WOO HJ, Yu C, Reifman J
    Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases.
    PLoS One. 2017;12:e0169918.
    PubMed     Text format     Abstract available


  127. WALSH AM, Wechalekar MD, Guo Y, Yin X, et al
    Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
    PLoS One. 2017;12:e0183928.
    PubMed     Text format     Abstract available


  128. ZHOU R, Lin X, Li DY, Wang XF, et al
    Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach.
    PLoS One. 2017;12:e0183842.
    PubMed     Text format     Abstract available


  129. EBINA K, Hirao M, Takagi K, Ueno S, et al
    Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0183805.
    PubMed     Text format     Abstract available


  130. LIU R, Gao C, Chen H, Li Y, et al
    Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
    PLoS One. 2017;12:e0173301.
    PubMed     Text format     Abstract available


  131. SHIELDS KJ, Mollnes TE, Eidet JR, Mikkelsen K, et al
    Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.
    PLoS One. 2017;12:e0174577.
    PubMed     Text format     Abstract available


  132. LACKNER A, Ficjan A, Stradner MH, Hermann J, et al
    It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjogren's Syndrome - A qualitative study.
    PLoS One. 2017;12:e0172056.
    PubMed     Text format     Abstract available


  133. MORIYA N, Shibasaki S, Karasaki M, Iwasaki T, et al
    The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.
    PLoS One. 2017;12:e0169702.
    PubMed     Text format     Abstract available


  134. MOURA RA, Quaresma C, Vieira AR, Goncalves MJ, et al
    B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
    PLoS One. 2017;12:e0182927.
    PubMed     Text format     Abstract available


  135. SCRIVO R, Massaro L, Barbati C, Vomero M, et al
    The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
    PLoS One. 2017;12:e0184449.
    PubMed     Text format     Abstract available


  136. PETERS M, Scharmga A, de Jong J, van Tubergen A, et al
    An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints.
    PLoS One. 2017;12:e0175829.
    PubMed     Text format     Abstract available


  137. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Text format     Abstract available


  138. QU S, Du Y, Chang S, Guo L, et al
    Common variants near IKZF1 are associated with primary Sjogren's syndrome in Han Chinese.
    PLoS One. 2017;12:e0177320.
    PubMed     Text format     Abstract available


  139. CHAO WC, Lin CH, Liao TL, Chen YM, et al
    Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren's syndrome: A nationwide, population-based case-control study.
    PLoS One. 2017;12:e0176549.
    PubMed     Text format     Abstract available


  140. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation.
    PLoS One. 2017;12:e0180879.
    PubMed     Text format     Abstract available


  141. FIDELIX T, Czapkowski A, Azjen S, Andriolo A, et al
    Salivary gland ultrasonography as a predictor of clinical activity in Sjogren's syndrome.
    PLoS One. 2017;12:e0182287.
    PubMed     Text format     Abstract available


  142. RIFBJERG-MADSEN S, Christensen AW, Christensen R, Hetland ML, et al
    Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
    PLoS One. 2017;12:e0180014.
    PubMed     Text format     Abstract available


  143. HUANG LG, Chen G, Chen DY, Chen HH, et al
    Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186346.
    PubMed     Text format     Abstract available


  144. MAROUEN S, du Cailar G, Audo R, Lukas C, et al
    Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls.
    PLoS One. 2017;12:e0186157.
    PubMed     Text format     Abstract available


  145. JARDEL S, Fabien N, Hot A, Vukusic S, et al
    Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey.
    PLoS One. 2017;12:e0185104.
    PubMed     Text format     Abstract available


  146. CHEN FY, Lee A, Ge S, Nathan S, et al
    Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome.
    PLoS One. 2017;12:e0184916.
    PubMed     Text format     Abstract available


  147. CHEN X, Utheim OA, Xiao J, Adil MY, et al
    Meibomian gland features in a Norwegian cohort of patients with primary Sjogren s syndrome.
    PLoS One. 2017;12:e0184284.
    PubMed     Text format     Abstract available


  148. LIN CH, Chen DY, Chao WC, Liao TL, et al
    Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0182284.
    PubMed     Text format     Abstract available


  149. MENG Z, Klinngam W, Edman MC, Hamm-Alvarez SF, et al
    Interferon-gamma treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjogren's Syndrome.
    PLoS One. 2017;12:e0184781.
    PubMed     Text format     Abstract available


  150. KIM KH, Kim DH, Jeong HJ, Ryu JS, et al
    Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjgren's syndrome.
    PLoS One. 2017;12:e0183678.
    PubMed     Text format     Abstract available


  151. NARAYAN N, Mandhair H, Smyth E, Dakin SG, et al
    The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages.
    PLoS One. 2017;12:e0185767.
    PubMed     Text format     Abstract available


  152. STACK JR, Madigan A, Helbert L, Dunne E, et al
    Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    PLoS One. 2017;12:e0188027.
    PubMed     Text format     Abstract available


  153. YUAN M, Wang S, Yu L, Qu B, et al
    Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186795.
    PubMed     Text format     Abstract available


  154. STACK RJ, Southworth S, Fisher BA, Barone F, et al
    A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome.
    PLoS One. 2017;12:e0187272.
    PubMed     Text format     Abstract available


  155. CHEN YM, Chen HH, Huang WN, Liao TL, et al
    Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
    PLoS One. 2017;12:e0188454.
    PubMed     Text format     Abstract available


  156. LIN TT, Wu CK, Liao MT, Yang YH, et al
    Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
    PLoS One. 2017;12:e0188720.
    PubMed     Text format     Abstract available


  157. BEALS C, Baumgartner R, Peterfy C, Balanescu A, et al
    Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
    PLoS One. 2017;12:e0187397.
    PubMed     Text format     Abstract available


  158. HORNBERG K, Sundstrom B, Innala L, Rantapaa-Dahlqvist S, et al
    Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.
    PLoS One. 2017;12:e0190211.
    PubMed     Text format     Abstract available


  159. DUHN PH, Sode J, Hagen CM, Christiansen M, et al
    Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations.
    PLoS One. 2017;12:e0188492.
    PubMed     Text format     Abstract available


  160. WANG B, Zhao P, Zhou Y, Meng L, et al
    Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats.
    PLoS One. 2017;12:e0188199.
    PubMed     Text format     Abstract available


  161. SCHAAL JB, Tran DQ, Subramanian A, Patel R, et al
    Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide.
    PLoS One. 2017;12:e0187868.
    PubMed     Text format     Abstract available


  162. HORNUM L, Hansen AJ, Tornehave D, Fjording MS, et al
    C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    PLoS One. 2017;12:e0189017.
    PubMed     Text format     Abstract available


  163. ALMEIDA D, Vianna K, Arriaga P, Moraschini V, et al
    Dental implants in Sjogren's syndrome patients: A systematic review.
    PLoS One. 2017;12:e0189507.
    PubMed     Text format     Abstract available


    January 2016
  164. MORI S, Hidaka M, Kawakita T, Hidaka T, et al
    Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    PLoS One. 2016;11:e0154744.
    PubMed     Text format     Abstract available


  165. MANOUSEK J, Stejskal V, Kubena P, Jarkovsky J, et al
    Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome - Is There a Clinical Relevance?
    PLoS One. 2016;11:e0164786.
    PubMed     Text format     Abstract available


  166. CHEN J, Zhao X, Liu H, Zhou S, et al
    A Point-Scoring System for the Clinical Diagnosis of Sjogren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland.
    PLoS One. 2016;11:e0155666.
    PubMed     Text format     Abstract available


  167. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0161958.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: